Solti Innovative Breast Cancer Research

Research facility

Location: Barcelona, Spain (ES)

Publications

(2)

Identification of Patients with Early HR+ HER2- Breast Cancer at High Risk of Recurrence (2024) Fasching P, Kreipe H, Del Mastro L, Ciruelos E, Freyer G, Korfel A, Chouaki N, et al. Journal article, Review article Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE) (2017) Loibl S, De La Pena L, Nekljudova V, Zardavas D, Michiels S, Denkert C, Rezai M, et al. Journal article